A New Rapidly Absorbed Paracetamol Tablet Containing Sodium Bicarbonate. II. Dissolution Studies and In Vitro/In Vivo Correlation

REFERENCES

• Meyer M.C., Straughn A.B., Jarvi E.J., Wood J.C., Pelsor F.R., Shah V.P. The Bioequivalence of Carbamazepine Tablets with a History of Clinical Failures. Pharm. Res. 1992; 9: 1612–1616
   PubMed Web of Science ®Google Scholar
• Shah V.P., Knight P., Prasad V.K., Cabana B.E. Thiazides. IV. Comparison of Dissolution with Bioavailability Of Chlorothiazide Tablets. J. Pharm. Sci. 1982; 71: 822–824
   PubMed Web of Science ®Google Scholar
• Shah V.P., Prasad V.K., Freeman C., Skelly J.P., Cabana B.E. Phenytoin. II. In Vitro Dissolution Bioequivalence Standard for 100 mg Phenytoin Sodium Capsules. J. Pharm. Sci. 1983; 72: 309–310
   PubMed Web of Science ®Google Scholar
• Steinijans V.W., Dietrich R., Trautmann H., Sauter R., Benedikt G. A Novel Approach to the Specification of In Vitro Dissolution Boundaries Based on Regulatory Requirements for Bioequivalence. Drug Res. 1988; 38: 1238–1240
   Web of Science ®Google Scholar
• Abuzarur-Aloul R, Gjellan K., Sjolund M., Graffner C. Critical Dissolution Tests of Oral Systems Based on Statistically Designed Experiments. III. In Vitro In Vivo Correlation for Multiple-Unit Capsules of Paracetamol Based on PLS Modelling. Drug. Dev. Ind. Pharm. 1998; 24(4)371–383
   PubMed Web of Science ®Google Scholar
• Radovanovi J., Duri Z., Jovanovi M., Ibri S., Petrovi M. An Attempt to Establish In Vitro-In Vivo Correlations: Case of Paracetamol Immediate-Release Tablets. Eur. J. Drug. Metab. Pharm. 1998; 23: 30–40
   Google Scholar
• Dimínguez A., Medina L.R., Hurtado P.M. Bioequivalence Study of Paracetamol Tablets: In Vitro–In Vivo Correlation. Drug. Dev. Ind. Pharm. 2000; 26: 821–828
   PubMed Web of Science ®Google Scholar
• Rostami-Hodjegan A., Tucker G.T., Ayesh R., Darby-Dowman A., Grattan T.J. A New Rapidly Absorbed Paracetamol Tablet Containing Sodium Bicarbonate. I. A Four Way Crossover Study to Compare the Concentration–Time Profile of Paracetamol from the New Paracetamol/Sodium Bicarbonate Tablet and a Conventional Paracetamol Tablet in Fed and Fasted Volunteers. Drug Dev. Ind. Pharm., (this issue)
   Web of Science ®Google Scholar
• Polli J.E., Crison J.R., Amidon G.L. Novel Approach to the Analysis of In Vitro–In Vivo Relationships. J. Pharm. Sci. 1996; 85: 753–760
   PubMed Web of Science ®Google Scholar
• Dunne A., O’Hara T., Devane J. Level A In Vivo–In Vitro Correlation: Nonlinear Models and Statistical Methodology. J. Pharm. Sci. 1997; 85: 1245–1249
   Google Scholar
• USP 24. The United States Pharmacopeial Convention, Rockville, MD 1999; 19–20
   Google Scholar
• Moore I.W., Flanner H.H. Mathematical Comparison of Curves with an Emphasis on In Vitro Dissolution Profiles. Pharm. Tech. 1996; 20: 64–74
   Google Scholar
• FDA Guidance for Industry. Immediate Release Solid Oral Dosage Forms: Scale-up and Post-approval Changes (SUPAC-IR)—Chemistry, Manufacturing, and Controls. In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation. Nov, 1995
   Google Scholar
• CPMP Note for Guidance on Investigation of Bioavailability and Bioequivalence. Dec, 2000
   Google Scholar
• Shah V.P., Tsong Y.I., Sathe P., Liu J.P. In Vitro Dissolution Profile Comparison—Statistics and Analysis of the Similarity Factor, f2. Pharm. Res. 1998; 15: 889–896
   PubMed Web of Science ®Google Scholar
• Kristensen H.G. Note on the Monograph Dissolution Test from Solid Dosage Forms. Pharmaeuropa 1996; 8(3)386–392
   Google Scholar
• FIP Guidelines for Dissolution Testing of Solid Oral Products. Joint Report of the Section for the Official Laboratories and Medicines Control Services of Industrial Pharmacists of the FIP. Dec, 1996
   Google Scholar
• Eichman J.D., Yassin A.E.B., Robinson J.R. The Influence of In-Vivo Carbonation on GI Physiological Processes and Drug Permeability. Eur. J. Pharm. Biopharm. 1997; 44: 33–38
   Web of Science ®Google Scholar
• Eichman J.D., Robinson J.R. Mechanistic Studies on Effervescent Induced Permeability Enhancement. Pharm. Res. 1998; 15(6)925–930
   PubMed Web of Science ®Google Scholar
• Grattan T., Hickman R., Darby-Dowman A., Hayward M., Boyce M., Warrington S. A Five Way Crossover Human Volunteer Study to Compare the Pharmacokinetics of Paracetamol Following Oral Administration of Two Commercially Available Paracetamol Tablets and Three Development Tablets Containing Paracetamol in Combination with Sodium Bicarbonate or Calcium Carbonate. Eur. J. Pharm. Biopharm. 2000; 43(3)225–229
   Web of Science ®Google Scholar
• O'Mahoney B., Foster J., Soutar S., Wilson C.G., McMillan N. Investigation into the Prokinetic Action of Sodium Bicarbonate in Man Using Magnetic Resonance Imaging. J. Pharm. Pharmacol. 2000; 52(Suppl.)6
   Google Scholar
• Hunt J.N., Pathak J.D. The Osmotic Effect of Some Simple Molecules and Ions on Gastric Emptying. J. Physiol. 1960; 154: 254–269
   PubMed Web of Science ®Google Scholar
• Bell F.R., Mostaghni K. Duodenal Control of Gastric Emptying in the Milk Fed Calf. J. Physiol. 1975; 245: 387–407
   PubMed Web of Science ®Google Scholar
• Hunt J.N., Knox M.T. The Slowing of Gastric Emptying by Four Strong Acids and Three Weak Acids. J. Physiol. 1972; 222: 187–208
   PubMed Web of Science ®Google Scholar
• Skelly J.P., Shiu G.F. In Vitro–In Vivo Correlations in Biopharmaceutics—Scientific and Regulatory Implications. Eur. J. Drug. Metab. Pharmac. 1993; 18: 121–129
   PubMed Web of Science ®Google Scholar
• Dressman J.B., Amidon G.L., Reppas C., Shah V.P. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms. Pharm. Res. 1998; 15: 11–22
   PubMed Web of Science ®Google Scholar
• Tandt L., Stubbs C., Kanfer I. Level A In Vitro/In Vivo Correlations—A Quality Control Tool or Bioequivalence Predictor for Extended Release Solid Oral Dosage Forms. Drug Dev. Ind. Pharm. 1995; 21(8)889–904
   Web of Science ®Google Scholar
• Katori N., Aoyagi N., Terao T. Estimation of Agitation Intensity in the GI Tract in Humans and Dogs Based on In Vitro/In Vivo Correlation. Pharm. Res. 1995; 12: 237–243
   PubMed Web of Science ®Google Scholar
• Mojaverian P., Radwanski E., Lin C.C., Cho P., Vadino W.A., Rosen J.M. Correlation of In Vitro Release Rate and In Vivo Absorption Characteristics of 4 Chlorpheniramine Maleate Extended-Release Formulations. Pharm. Res. 1992; 9: 450–456
   PubMed Web of Science ®Google Scholar
• Balan G., Timminus P., Greene D.G., Marathe P.H. In Vitro–In Vivo Correlation Models for Glibenclamide After Administration of Metformin/Glibenclamide Tablets to Healthy Human Volunteers. J. Pharm. Pharmacol. 2000; 52: 831–838
   PubMed Web of Science ®Google Scholar
• Theiß U., Gebbardt E., Müller J. Untersuchungen zur Bioäquivalenz Jeweils Zwei Chargen Zweier Nifedipin-Retard-Formulierungen bei Mangelnder Chargenkonformität aus In-Vitro-Freisetzungsuntersuchungen. Drug Res. 1992; 42: 629–632
   Google Scholar
• Rostami-Hodjegan A., Jackson P.R., Tucker G.T. Sensitivity of Indirect Metrics for Assessing “Rate” in Bioequivalence Studies—Moving the “Goalposts” or Changing the “Game.”. J. Pharm. Sci. 1994; 83: 1554–1557
   PubMed Web of Science ®Google Scholar
• Elkoshi Z. Dissolution Specifications Based on Release Rates. J. Pharm. Sci. 1999; 88: 434–444
   PubMed Web of Science ®Google Scholar
• Cutler D.J., Beyssac E., Aiache J.M. Level B and C In Vitro/In Vivo Correlations Statistical Considerations. Int. J. Pharm. Sci. 1997; 158(2)185–193
   Web of Science ®Google Scholar